1. McMahon T, Wright EL (1996) Introduction. In: Sherman RE, Rhodes LJ (eds) Analytical instrumentation: practical guides for measurement and control. Instrument Society of America, Research Triangle Park, NC
2. FDA (2004) Guidance for industry. PAT—a framework for innovative pharmaceutical development, manufacturing, and quality assurance. US Food and Drug Administration (Center for Drug Evaluation and Research, CDER), Washington, DC (see http://www.fda.gov/cder/guidance/6419fnl.htm )
3. FDA (2004) Pharmaceutical CGMPs for the 21st century—a risk-based approach. Final Report, September 29, 2004. US FDA (CDER), Washington, DC (see http://www.fda.gov/cder )
4. Cooley RE, Egan C (2004) The impact of process analytical technology (PAT) on pharmaceutical manufacturing. Am Pharm Rev 7(1):62
5. Bussche KV (2005) UOP, process intensification through component miniaturization: current status, gaps, and the role of process analytical techniques. Presentation, CPAC Summer Institute 2004 Report (see http://www.cpac.washington.edu )